Biotech Series A Investors & VC Firms
1626 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.
TEDCO
ColumbiaPre-Seed–Series A
8 people
Industrifonden
StockholmPre-Seed–Series A$960K – $4.8M
34 people
Colopl Next
TokyoSeed–Growth
17 people
South Park Commons
San FranciscoPre-Seed–Late Stage$1M – $10M
13 people
Backed
LondonPre-Seed–Series A$500K – $5M
32 people
SBI Investment Korea Co. Ltd.
SeoulSeries A–Series C$200K – $10M
33 people
Optum Ventures
BostonSeed–Growth
35 people
ID Ventures
DetroitPre-Seed–Series A$50K – $250K
8 people
Catalio Capital Management, LP
New YorkSeed–Late Stage
37 people
Madrona Venture Labs
SeattleSeed–Series A
64 people
Nazca
Mexico CityPre-Seed–Late Stage
32 people
Rev1 Ventures
ColumbusPre-Seed–Series A
53 people
UTokyo Innovation Platform Co. Ltd.
TokyoPre-Seed–Growth
21 people
Prosperity7 Ventures
DhahranSeries A–Growth
43 people
WI Harper Group
San FranciscoSeed–Series A$5M – $15M
28 people
Golden Ventures
TorontoPre-Seed–Series A$500K – $2.5M
9 people
Vida Ventures
Los AngelesPre-Seed–Late Stage
44 people
Casdin Capital
New YorkSeed–Series C
38 people
Pappas Capital
DurhamSeed–Series A
34 people
Dolby Family Ventures
San FranciscoPre-Seed–Series A
20 people
UpHonest Capital
Silicon ValleyPre-Seed–Series B$50K – $1M
24 people
Beyond Next Ventures
TokyoSeed–Series A
36 people
Two Sigma Ventures
New YorkSeed–Series B$2M – $15M
26 people
ZhenFund
BeijingPre-Seed–Series A$250K – $3M
36 people
Related lists
Series A Investors & VC Firms (7326)Series A Investors & VC Firms in North America (4220)Series A Investors & VC Firms in United States (3839)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2591)Biotech Investors & VC Firms (2475)Series A Investors & VC Firms in Europe (2384)Fintech Series A Investors & VC Firms (2350)Healthtech Series A Investors & VC Firms (2310)Enterprise Software Series A Investors & VC Firms (2265)
Data sourced from public filings and firms' own websites — see our methodology.







































































































